These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 28513507

  • 1. Early pregnancy plasminogen activator inhibitor-1 levels in Nigerian women and its relationship with preeclampsia.
    Udenze IC, Arikawe AP, Makwe CC.
    Niger J Clin Pract; 2017 May; 20(5):517-522. PubMed ID: 28513507
    [Abstract] [Full Text] [Related]

  • 2. A prospective cohort study on the clinical utility of second trimester mean arterial blood pressure in the prediction of late-onset preeclampsia among Nigerian women.
    Udenze IC, Arikawe AP, Makwe CC, Olowoselu OF.
    Niger J Clin Pract; 2017 Jun; 20(6):741-745. PubMed ID: 28656930
    [Abstract] [Full Text] [Related]

  • 3. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia.
    Purwosunu Y, Sekizawa A, Koide K, Farina A, Wibowo N, Wiknjosastro GH, Okazaki S, Chiba H, Okai T.
    Clin Chem; 2007 Mar; 53(3):399-404. PubMed ID: 17234729
    [Abstract] [Full Text] [Related]

  • 4. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A, Kobayashi T, Terao T.
    Gynecol Obstet Invest; 1996 Mar; 42(2):95-101. PubMed ID: 8878712
    [Abstract] [Full Text] [Related]

  • 5. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
    Estellés A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR.
    Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307
    [Abstract] [Full Text] [Related]

  • 6. Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia.
    Bodova KB, Biringer K, Dokus K, Ivankova J, Stasko J, Danko J.
    Dis Markers; 2011 Sep; 30(4):191-6. PubMed ID: 21694445
    [Abstract] [Full Text] [Related]

  • 7. Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia.
    He S, Bremme K, Blombäck M.
    Blood Coagul Fibrinolysis; 1995 Dec; 6(8):703-8. PubMed ID: 8825219
    [Abstract] [Full Text] [Related]

  • 8. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia.
    Shaarawy M, Didy HE.
    Int J Gynaecol Obstet; 1996 Nov; 55(2):135-9. PubMed ID: 8960994
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
    Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J.
    Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
    [Abstract] [Full Text] [Related]

  • 12. A longitudinal study of biochemical variables in women at risk of preeclampsia.
    Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L.
    Am J Obstet Gynecol; 2002 Jul; 187(1):127-36. PubMed ID: 12114900
    [Abstract] [Full Text] [Related]

  • 13. Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.
    Ajibola SO, Adeyemo TA, Afolabi BB, Akanmu AS.
    Niger Med J; 2016 Jul; 57(4):213-6. PubMed ID: 27630384
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole.
    Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B.
    Br J Obstet Gynaecol; 1993 Apr; 100(4):370-4. PubMed ID: 8494839
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy.
    Ayala DE, Hermida RC.
    Chronobiol Int; 2013 Mar; 30(1-2):233-59. PubMed ID: 23006127
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I.
    Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
    [Abstract] [Full Text] [Related]

  • 18. Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia.
    Roes EM, Sweep CG, Thomas CM, Zusterzeel PL, Geurts-Moespot A, Peters WH, Steegers EA.
    Am J Obstet Gynecol; 2002 Oct; 187(4):1019-25. PubMed ID: 12388999
    [Abstract] [Full Text] [Related]

  • 19. Study of plasma adrenomedullin level in normal pregnancy and preclampsia.
    Senna AA, Zedan M, el-Salam GE, el-Mashad AI.
    Medscape J Med; 2008 Feb 06; 10(2):29. PubMed ID: 18382699
    [Abstract] [Full Text] [Related]

  • 20. Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia?
    Kamal M, El-Khayat W.
    J Investig Med; 2011 Oct 06; 59(7):1147-50. PubMed ID: 21849906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.